Epithelial Responses to Bacterial Invasion

NIH RePORTER · NIH · R01 · $381,250 · view on reporter.nih.gov ↗

Abstract

Summary The intestinal mucosa serves as a barrier to infection from pathogens and normal gut flora. This barrier is defended by the mucosal immune system through a variety of innate and adaptive immune mechanisms. However, mucosal immune responses must be tightly regulated to maintain tolerance to resident normal flora and food antigens. Because peripheral tolerance cannot be explained completely by immunological ignorance or negative selection in the thymus, various mechanisms have been proposed for how lamina propria macrophages (MPs) and dendritic cells (DCs) capture and present luminal antigen in the steady-state to promote intestinal homeostasis. Recently, we described a novel luminal antigen transport mechanism that we've termed goblet cell associated antigen passages (GAPs). The role of GAPs in peripheral tolerance vs. immunity is relatively unexplored, but GAPs deliver small soluble antigens preferentially to CD103+ DCs, which have tolerogenic potential. A key question is whether pathogen invasion mechanisms have evolved to target steady-state antigen acquisition pathways (e.g., GAPs) as a strategy to evade the acute immune response. These studies will use a common and often deadly bacterial pathogen, Listeria monocytogenes (Lm), to investigate how initial host-bacterial interactions (minutes to hours) affects mucosal immunity and link invasion pathways to downstream infection outcomes. Our hypothesis is that bacterial invasion via GAPs will lead to inefficient innate and adaptive immune responses and increase bacterial persistence in the host. This hypothesis will be tested in vivo using a murinized Lm strain (Lm InlAMt) mouse that can infect mice orally and complemented by studying Lm InlAWt infection in explanted human intestinal tissues. These studies build on important recent developments including the murinized Lm oral infection model, in vivo two-photon imaging of the intestine and mesenteric lymph nodes, the development of a human explant infection system and state-of- the-art RNA sequencing approaches to characterize epithelial responses. This work is conceptually innovative in that it examines the first few minutes of an infection, which is rarely studied in vivo and impractical to study in human patients, but which may ultimately determine infection outcomes.

Key facts

NIH application ID
10077477
Project number
5R01AI077600-10
Recipient
WASHINGTON UNIVERSITY
Principal Investigator
MARK James MILLER
Activity code
R01
Funding institute
NIH
Fiscal year
2021
Award amount
$381,250
Award type
5
Project period
2009-08-01 → 2022-11-30